Personalized Medicine in lung Cancer

The era of personalized treatment for lung cancer will involve a comprehensive genomic characterization of adenocarcinoma, squamous-cell carcinoma, and small-cell carcinoma into various subtypes. Precision medicine is to develop treatments that exploit weak spots in tumor cells to destroy only the cancer cells (as compared to traditional chemotherapy and radiation). Weak spots have been found in two genes, EGFR and ALK, both found in adenocarcinoma NSCLC.

  • Lung cancer surgery
  • Management of Chemotherpay
  • Non-smallcell lung cancer
  • Pathogenesis
  • Lung cancer clinical trials and research

Related Conference of Personalized Medicine in lung Cancer

November 13-14, 2017

14th Asia Pacific Pathology Congress

Osaka, Japan
April 18-19, 2018

17th Conference on Oral & Maxillofacial Pathology

Las Vegas, Nevada, USA
June 20-21, 2018

15th European Pathology Congress

| Paris, France
June 25-26, 2018

15th CME Congress on Pathology and Cancer Research

Vancouver, Canada
August 27-28, 2018

4th International Conference on Cytopathology & Histopathology

Boston | Massachusetts | USA

Personalized Medicine in lung Cancer Conference Speakers

Recommended Sessions

Related Journals

Are you interested in